Publications - University of Michigan Michigan Center for Infectious Disease Threats

Hierarchy of controls as applied to COVID-19 control strategies. Source: Adapted from National Institute for Occupational Safety and Health (NIOSH) guidelines (Cornell University, n.d.). Its an inverted triangle, with Eilimation at the top, then substitution, then engineering controls, administrative controls, and finally PPE

Shared sanitation facilities and risk of respiratory virus transmission in resource-poor settings: A COVID-19 modeling case study

July 9, 2025

(A) Pooled relative distribution of DENV serotypes circulating yearly in inapparent and symptomatic primary DENV infections across multiple imputations. Transparency was added in years with infection count

Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in Nicaragua

April 1, 2025

Multiple figures that show RBCs from WT but not Erytlr9–/– mice acquire microbial DNA and demonstrate morphologic changes during sepsis. The rest of the explanation is on the caption of this figure on the paper, which is figure 1

Red blood cells capture and deliver bacterial DNA to drive host responses during polymicrobial sepsis

March 31, 2025

A figure that shows the study set up for this research. It is a US based study of high and average risk asymptomatic women enrolled in device collection trial to detect cervical intraepithelial neoplasia grade 2 or worse (CIN2+), 2020–2022

Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping

March 25, 2025

Proportions of deaths that could potentially have been averted if minoritized Michigan residents had experienced the same timing of infection as white residents during 2020. Vertical lines indicate the width of 95% posterior credible intervals. Abbreviation: AAPI, Asian American or Pacific Islander. 17% AAPI, 35% Black, and 9% of Latino Deaths could have been averted

Timing of Infection as a Key Driver of Racial/Ethnic Disparities in Coronavirus Disease 2019 Mortality Rates During the Prevaccine Period

February 24, 2025

Graphical Summary of results showing their mouse model. Summary of results. (A) Comparison of survival of WT C57BL/6 mice and PKR-TKO mice upon infection with WT MAV-1 at ~1 LD50 (102 PFU). “X” indicates knockout of PKR in the PKR-TKO mice. Data based on Fig. 3 and Table 1. (B) Comparison of survival of WT and PKR-TKO mice upon infection by mutant E4orf6TMC2 virus at the maximum dose, 107 PFU. The E4orf6 change of three amino acids in the Cul2-binding site is indicated by the “X” on the mutant virus

Role of mouse adenovirus type 1 E4orf6-induced degradation of protein kinase R in pathogenesis

February 10, 2025

Forest plot for the primary outcome of clinical success across key subgroups. Adjusted ORs were calculated after controlling for age (≥65 years or

Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study

January 21, 2025

graphical abstract of the study, highlighting - Staggered TLR and IFNAR signaling guide MRSA-induced metabolic remodeling in macrophages - Infection-induced NO, disrupts the respiratory chain modulating IL-1b and IFN-b production - Histone lactylation represses Nos2 and limits NO, -driven IFNb production - Chronic type I IFN blunts histone lactylation

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection

October 1, 2024

Box plot and scatter plots indicating that Baseline airway microbiome features associated with longitudinal lung function outcome. (A) Baseline sputum α-diversity between the trajectory groups: stable/improved, decline, and rapid decline. (B) Bacterial genera associated with categorical FEV1 trajectory using linear discriminant analysis effect size (27). LDA = linear discriminant analysis score from linear discriminant effect size analysis (LEfSe)

Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease

September 6, 2024